JOIN WITH US IN SUPPORTING NIH STAFF

Image of a person at a rally with a neon green sign that says: NIH funding saves lives and creates job

The Bethesda Declaration: A Call for NIH and HHS Leadership to Deliver on Promises of Academic Freedom and Scientific Excellence 

Dear Dr. Bhattacharya,

For staff across the National Institutes of Health (NIH), we dissent to Administration policies that undermine the NIH mission, waste public resources, and harm the health of Americans and people across the globe. Keeping NIH at the forefront of biomedical research requires our stalwart commitment to continuous improvement. But the life-and-death nature of our work demands that changes be thoughtful and vetted. We are compelled to speak up when our leadership prioritizes political momentum over human safety and faithful stewardship of public resources.

Many have raised these concerns to NIH leadership, yet we remain pressured to implement harmful measures. Today, we come directly to you. We include Secretary Kennedy and members of Congress who oversee NIH. We look forward to working with you and Department of Health and Human Services (HHS) leadership to maintain NIH as the world leader of biomedical research.

Our Shared Commitment to Academic Freedom

Academic freedom is a core scientific principle, and we deeply appreciate your public commitment to it at your confirmation hearing, in your April 24 statement on academic freedom, and in recent media interviews. You said: "I will establish a culture of respect for free speech in science and scientific dissent at the NIH," "Dissent is the very essence of science," and "...dissenting voices need to be heard and allowed." We hope you will welcome this dissent, which we modeled after your Great Barrington Declaration.

Our Concerns

This Administration has forced NIH, under your watch, to:

1) Politicize research by halting high-quality, peer reviewed grants and contracts. Academic freedom should not be applied selectively based on political ideology. To achieve political aims, NIH has targeted multiple universities with indiscriminate grant terminations, payment freezes for ongoing research, and blanket holds on awards regardless of the quality, progress, or impact of the science. Based on political preferences and without input from NIH scientific staff or Congress, NIH is censoring critical research and programs addressing:

  • Health disparities. U.S. Law (42 U.S.C. § 282) states that NIH shall "utilize diverse study populations, with special consideration to biological, social, and other determinants of health that contribute to health disparities." Yet, NIH has stigmatized and abruptly cut off funding for research mislabeled "Diversity Equity and Inclusion (DEI)." Achieving your stated goal to "solve the American chronic disease crisis” requires research addressing the social and structural drivers of health disparities.

  • COVID-19, long COVID, and immunization. We still have much to learn about the health and social consequences of COVID-19 and our response. Such research is needed to reduce the risk of future pandemics, optimize pandemic response policies, and address the well-documented and debilitating consequences of long COVID.

  • Health impacts of climate change. Substantial evidence shows human-driven climate change leads to higher rates of disease and death, such as asthma, heart disease, and stillbirths. Research is critical to find effective ways to reduce these and other health impacts of climate change.

  • Gender identity, sexual health, and the needs of intersex people in the U.S. These topics deserve research attention, and NIH has a long tradition of supporting rigorous research in these fields.

  • Broad participation in biomedical research. Robust research shows diverse teams outperform homogeneous ones. A broad workforce strengthens research capacity and supports globally competitive science. Due to misunderstanding of its workforce diversity programs, NIH terminated top-scoring grants to scientists from underrepresented backgrounds, while maintaining poorer-scoring grants from standard pathways, contrary to the merit-based system that makes NIH a global research leader.

Since January 20, 2025, NIH has terminated 2,100 research grants totaling around $9.5 billion and $2.6 billion in contracts. This undercuts long-standing NIH policies designed to maximize return on investment by working with grantees to address concerns and complete studies. Many terminations contradict federal regulations that mandate protections for research participants and require grant awards to specify potential termination reasons. These terminations:

  • Throw away years of hard work and millions of dollars. Ending a $5 million research study when it is 80% complete does not save $1 million, it wastes $4 million.

  • Shirk commitments to participants, who braved personal risk to give the incredible gift of biological samples, understanding that their generosity would fuel scientific discovery and improve health.

  • Risk participant health. NIH trials are being halted without regard to participant safety, abruptly stopping medications or leaving participants with unmonitored device implants.

  • Damage hard-earned public trust, counter to your stated goal to improve trust in NIH.

We urge you as NIH Director to restore grants delayed or terminated for political reasons so that life-saving science can continue.

2) Interrupt global collaboration. We would gladly work with you to improve existing systems to monitor awards with foreign components. But dissolving foreign collaborations while we await new procedures harms research participants and slows scientific discovery, cutting American scientists off from the global scientific community, preventing access to technologies only available abroad, and eliminating critical research that crosses political borders. We urge you as NIH Director to allow rigorously peer-reviewed research with vetted foreign collaborators to continue without disruption.

3) Undermine peer review. Independent peer review is the bedrock of NIH science, directing scarce resources toward the most impactful research and ensuring credible findings that can lead to better health. Without independent peer review, we risk losing scientific integrity and public trust. NIH is ignoring peer review to cater to political whims, pulling applications prior to review and removing high-scoring grants from funding consideration. HHS has redirected this funding to unvetted projects, like the Taubenberger-Memoli vaccine project. We urge you as NIH Director to restore peer review and hold political appointees to the same standards as other scientists.

4) Enact a blanket 15% cap on indirect costs. Until recently, indirect costs were negotiated using well-established criteria, accounting for critical research needs and very real costs, such as buildings, animal facilities, computers, libraries, and administrative support. The arbitrary 15% cap would hinder research, risk viability of universities and hospitals in states across the country, force universities to rescind graduate student positions, limit undergraduate research training, and damage the incredibly successful NIH-university partnerships that have improved health through scientific advances. We urge you as NIH Director to continue indirect rates that account for the research costs borne by academic institutions.

5) Fire essential NIH staff. The cuts to talented, hardworking professionals and critical departments without thought to their purpose or need has slowed the pace of science, held up extramural grant and contract funding, made NIH less transparent and efficient, and put Clinical Center patients at risk. We urge you as NIH Director to reinstate the people who make NIH work.

Delivering on your duty to obligate NIH funds

Combined, these actions have resulted in an unprecedented reduction in NIH spending that does not reflect efficiency but rather a dramatic reduction in life-saving research. Some may use the false impression that NIH funding is not needed to justify the draconian cuts proposed in the President's Budget. This spending slowdown reflects a failure of your legal duty to use congressionally-appropriated funds for critical NIH research. Each day that NIH continues to disrupt research, your ability to deliver on this duty narrows.

Who We Are

We are workers from every Institute and Center at NIH. We are devoted to the NIH mission: to seek and apply fundamental knowledge "to enhance health, lengthen life, and reduce illness and disability." We share your stated goal of supporting impactful research that, as you said at your confirmation hearing, is "vital to our country's future and, indeed, the world's." We work hard every day to carefully steward public funds to drive impactful, cutting-edge research. We want to work together to maintain NIH's tradition of excellence.

On June 9, 2025, we sign this declaration in Bethesda, Maryland, U.S. In addition to the named signers, we include anonymous signers and speak for countless others at NIH who share our concerns but who — due to a culture of fear and suppression created by this Administration — chose not to sign their names for fear of retaliation.

Click here to see the NIH Staff Signatories

Kathryn Adams

Deputy Director of the Office of Clinical

Research

NICHD

Rachel Bainbridge

IRTA Postdoctoral Fellow

NIEHS

Rakshita Balaji

NCCIH

James Baldassano, Ph.D.

NIDCD

Christina Barnett

OD

Matthew Brown

Postdoctoral Fellow

NICHD

Kelly Chen (they/them)

Postbaccalaureate Research Fellow

NHGRI

Sylvia Chou

Program Officer

NCI

EB Dickinson

Postbaccalaureate Fellow

NLM

Matthew Diller

Postdoctoral Fellow

NLM

Lee Eiden

Principal Investigator

NIMH

Peter Eriksson

Staff Scientist

NICHD

E King

NIH

Benjamin Feldman

Staff Scientist

NICHD

Melani LeDu

Grants Management Analyst

NICHD

Gerald (Jerry) Marti

Special Volunteer

NHLBI

Anuja Matthew

Scientific Review Officer

NIAID

Jennifer Meyers

Scientific Review Officer

NIAID

Keith A. Mintzer, Ph.D.

Program Officer

NHLBI

Douglas Monroe

Fellow

NCI

Ian Morgan

Postdoctoral Fellow

NIGMS/NHLBI

Alexander Myers

Postbaccalaureate Research Fellow

NIDA

Brad Newsome

Program Officer

FIC

Jenna Norton

Program Officer

NIDDK

Leah Pappalardo

Graduate Student

NICHD

Vani Pariyadath

Chief, Behavioral and Cognitive

Neuroscience Branch

Division of Neuroscience and Behavior

NIDA

Sarah Morris

Program Officer and Branch Chief

NIMH

Katrina J. Serrano

Program Officer

NIDDK

Nina Silverberg

Program Officer

NIA

Janine Simmons

Deputy Director

DPCPSI/OBSSR

Marie Stoltzfus

Postdoctoral Fellow

NICHD

Asha Storm

Program Analyst

NIBIB

Candace Tingen

Branch Chief

NICHD

Rebecca Troisi

Senior Associate Scientist

NCI

Sarah Vidal

Program Officer

NIDA

Audrey Wellons, NCI

Carmen Williams, Senior Investigator, NIEHS

Saul Malozowski

Mollie Manier

Scientific Review Officer

CSR

Matthew Manion

Postdoctoral Fellow

NICHD

Luis Alvarado, PhD

Former HPS

NINDS

Probationary termination

Jourdan Ewoldt

Former

NCI

Probationary termination

Courtney Gallen

Former Program Officer

NICHD

Probationary termination

Jalina Graham

Former Health Program Specialist

NINDS

Probationary termination

Madison Haise

Former PMF Health Specialist

OD

Probationary termination

Cynthia Hurlbert

Administrative Assistant

NIAID

Subject to reductions in force

Erin Lavik

Former CTO and Deputy, Division of Cancer

Prevention, NCI

Probationary termination

JoBeth McCarthy

Former Social and Behavioral Health Science

Administrator

NCI CRCHD

Probationary termination

Dr. Robles

Former Program Officer

NIMH

Probationary termination

Catherine Timura, PhD

Senior Health Science Policy Analyst

NINR

Subject to reductions in force

Elizabeth Tuck

NHGRI

Subject to reductions in force

MSI

Health Former Program Specialist

NIA

Probationary termination

K.M.

Health Comms Specialist

NCI/OCPL

Subject to reductions in force

RMM,

Former Public Affairs Specialist

NIDDK

Probationary termination

C.R.

Former Program Analyst

NIH

Probationary termination

MR

Former Program Specialist

NEI

Probationary termination

R

Program Director

NCI

Subject to reductions in force

JMS

Former NIH

Probationary termination

Nicole S

Former HPS

NIH

Probationary termination

A. Doe

Program Officer

NCI

Anonymous

NIH

Anonymous

NIH

Anonymous

Fellow

NIH

Anonymous

NCATS

Anonymous

NCATS

Anonymous

NCCIH

Anonymous

NCI

Anonymous

NCI

Anonymous

NCI

Anonymous

NCI

Anonymous

NCI

Anonymous

NCI

Anonymous

NCI

Anonymous

NCI

Anonymous

NCI

Anonymous

NCI

Anonymous

NCI

Anonymous

NCI

Anonymous

NCI

Anonymous

NCI

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH OD

Anonymous

NIH OD

Anonymous

NIH OD

Anonymous

NIH OD

Anonymous

NIH OD

Anonymous

Program Director

NCI

Anonymous

Program Director

NCI

Anonymous

Program Director

NCI

Anonymous

Program Director

NIDDK

Anonymous

Program Officer

NCI

Anonymous

Program Officer

NHLBI

Anonymous

Program Officer

NIA

Anonymous

Program Officer

NIAID

Anonymous

Program Officer

NIAMS

Anonymous

Program Officer

NIDA

Anonymous

Program Officer

NIDA

Anonymous

Program Officer

NIDDK

Anonymous

Program Officer

NIDDK

Anonymous

Scientific Review Officer

CSR

Anonymous

Staff Scientist

NIAID

Anonymous

Staff Scientist

NIEHS

Chimbwido

NIH

Concerned Scientist

NIDDK

E

NIMH

Empowered

NIH

Jane Doe, PhD

Program Officer

NINDS

Jane Doe

Program Officer

NIH

Jane Doe

Program Specialist

NIH

Jane Doe

Scientist

NCI

Jane Snow

Epidemiologist

NCI

Juana Doe

NCI

Subject to reductions in force

Anonymous

NIH

Subject to reductions in force

Anonymous

NIH

Subject to reductions in force

Anonymous staffer

NIH

Subject to reductions in force

Anonymous

Administrative staff

NIMH

Subject to reductions in force

Anonymous

Budget Analyst

NIH

Subject to reductions in force

Anonymous

FIC

Subject to reductions in force

Anonymous

Former NICHD

Probationary termination

Anonymous

Former NIH

Probationary termination

Anonymous

Former NIH OD

Probationary termination

Anonymous

Former NINDS

Probationary termination

Anonymous

Former Presidential Management Fellow

NIH

Probationary termination

Anonymous

Former Program Manager

NIH

Probationary termination

Anonymous

NIAAA

Subject to reductions in force

Anonymous

NIAID

Probationary termination

Anonymous

NIAMS

Subject to reductions in force

Anonymous

NIAMS

Subject to reductions in force

Anonymous

NIH

Subject to reductions in force

Anonymous

NIH

Subject to reductions in force

Anonymous

NIH

Subject to reductions in force

Anonymous

NIMH

Subject to reduction in force

Anonymous

Workforce Analyst

NCI

Subject to reductions in force

Former Division Director

NIH

Subject to reductions in force

Anonymus

Health Specialist/Program Official

Subject to reductions in force

Tara Fischer

Research Fellow

NINDS

Nina Friedman (she/her)

Predoctoral Fellow

NIMH

Anne Gershenson

Program Officer

NIGMS

Alexander Grinberg

Core Director

NICHD

Paul Grothaus, PhD

Program Officer

NIA

Katie Hajdarovic

Postdoctoral Fellow

NIDDK

Shilpa Hattangadi, MD

Program Officer

NIDDK

Jenni Pacheco

Program Officer

NIMH

Sammy Katta

NIH

Theresa Kim

Program Officer

NIA

Sarah Kobrin

Branch Chief

NCI

Konrad Krzewski

Scientific Review Officer

NIAID

Rosa Lafer-Sousa

Special Volunteer

NIMH

Alexander Jordan Lara

Postbaccalaureate Fellow

NIDCR

Rui C. Pereira de Sá

Program Director

NIBIB

Shiv Prasad

Scientific Review Officer

NIAID

Cara Pugliese

Program Officer

NIMH

Lindsey Pujanandez

Scientific Review Officer

NIAID

Carolyn Reyes-Guzman

Program Officer

NCI

Marc Rigas

Program Officer

NIGMS

Arin Rinvelt

Postbaccalaureate Fellow

NICHD

John Ritchie

Visiting Fellow

NIMH

Amilcar Rodriguez

Predoctoral Fellow

SAA NIH Fellows United

Alexa Romberg

Program Officer

NIDA

Gina Roussos

NIH

Ann-Marie Roy

Acting Branch Chief

NIAID

Marcel Salive

Program Officer

NIA

Caitlyn Barnes

Peer Review Specialist

NIAID

Subject to reductions in force

M Boyle

Former NIH

Probationary termination

Cara Anjos Breeden

NIAAA

Subject to reductions in force

Bushraa Khatib

Former Science Writer/Editor

NIDCR

Probationary termination

R.Carter,

Former Management Analyst

NIAAA

Probationary termination

Ana Choban

Former NHLBI

Probationary termination

Anna Culbertson

Former Scientific Program Specialist

NIAID

Probationary termination

Kayla Davis

Resigned Senior Health Science Policy

Analyst,

DPCPSI, OD

Subject to reductions in force

D. DiSabato

Former NINDS

Probationary termination

Yasaman Etemadi

Former Administrative Assistant

CSR

Terminated contractor

Hannah Evans

Research Associate

NEI

Subject to reductions in force

Laura Machlin

Former Program Officer

NICHD

Probationary termination

KL

NIDA

JL

NIH

MN

Postdoctoral Fellow

NICHD

HAP

NIH

MF

Program Officer

NIMH

MR

Scientific Review Officer

CSR

N.S.

NCI

Maya S

NCI

SM

Staff Clinician

NIH

Maura C.

NCI

Subject to reductions in force

FMX

NIH

Subject to reductions in force

Emma

NIH

Probationary termination

AG

NIEHS

Subject to reductions in force

Anonymous

NCI

Anonymous

NIH

Anonymous

NIH

Anonymous

PI

NIH

Anonymous

Program Official

NIH

Anonymous Scientist

NIH

Anonymous

Branch Chief

NCI

Anonymous

Branch/Division Chief

NIH

Anonymous

Center for Scientific Review

Anonymous

Deputy Division Director

NIH

Anonymous

Fellow

NCI

Anonymous

Fellow

NIMH

Anonymous

Concerned Employee

NIH

Anonymous

Grants Management Specialist

NIH

Anonymous

Health Science Administrator

DPCPSI

Anonymous

NCI

Anonymous

NCI

Anonymous

NCI

Anonymous

NCI

Anonymous

NCI

Anonymous

NEI

Anonymous

NIAID

Anonymous

NIAID

Anonymous

NIBIB

Anonymous

NICHD

Anonymous

NIDA

Anonymous

NIDA

Anonymous

NIDDK

Anonymous

NIDDK

Anonymous

NIDDK

Subject to reductions in force

Anonymous

NIGMS

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

NIH

Anonymous

Concerned mother and American citizen

NIH

Anonymous

NIAID

Anonymous

NIMH

Anonymous

NIMH

Anonymous

NINDS

Anonymous

NINDS

Anonymous

NINR

Anonymous

OD

Anonymous

OD

Anonymous

Office of AIDS Research

Anonymous

Office of Communication

NICHD

Subject to reductions in force

Anonymous

OD

Anonymous

PI

NIH

Anonymous

Program Director

NCI

Anonymous

Program Director

NCI

Anonymous

Program Director

NCI

Anonymous

Program Officer

NIDDK

Anonymous

Program Officer

NIH

Anonymous

Program Officer

NIH

Anonymous

Program Officer

NIH

Anonymous

Program Officer

NIH

Anonymous

Program Officer

NIH

Anonymous

Program Officer

NIH

Anonymous

Program Officer

NIH

Anonymous

Program Officer

NIH

Anonymous

Program Officer

NIMH

Anonymous

Program Officer

NIMH

Anonymous

Scientific Review Officer

CSR

Anonymous

Scientific Review Officer

NIH

Anonymous

Scientist

NIMH

Liberte Toussaint Louverture

Anonymous

NIH

MC

Clinical Social Worker

CC

Melanie Doe

NIAAA

Anonymous

NIH OER

Scientist

NIH

Program Director

NIH

Jane Doe

NIH

Anonymous

Program Director

NCI

Program Official

NICHD

Program Official

NICHD

Scientist

NIH

Seriously Concerned

Program Director

NCI

Tina Doe

NIEHS

Yewi

Program Officer

NIH

Anonymous

NIH

Subject to reductions in force

Anonymous A

Former Program Analyst

NIAID

Probationary termination

Anonymous

Former Program Officer

NIA

Probationary termination

Anonymous,

Former System Administrator

NIH

Probationary termination

Anonymous

Health Specialist

NIEHS

Subject to reductions in force

Anonymous

Information Technology Specialist

NIMH

Subject to reductions in force

Anonymous

Management Analyst

NIAID

Subject to reductions in force

Anonymous

Management Analyst

NIA

Subject to reductions in force

Anonymous

NCI

Subject to reductions in force

Anonymous

NCI

Subject to reductions in force

Anonymous

NCI

Subject to reductions in force

Anonymous

NHGRI

Subject to reductions in force

Anonymous

NIA

Subject to reductions in force

Jane Doe

Management Analyst

NINDS

Subject to reductions in force

Purchasing agent

NIH

Subject to reductions in force

Anonymous

CC

Subject to reductions in force

R

Program Director

NCI

Subject to reductions in force

SEBA

NIH

Subject to reductions in force

The One Who Got Away

NIH

Subject to reductions in force

Truth matters

NCI

Subject to reductions in force

On June 9th, 2025 federal employees at the National Institutes of Health (NIH) bravely stood up for the health and safety of the American people and faithful stewardship of public resources by authoring and signing the Bethesda Declaration.

We the undersigned, stand united with these courageous and selfless public servants who are committed to their duty to the American people and the mission of the NIH, including fruitful partnership with academia.

Together, we stand up for science.

Click here to read the Open letter in support of the Bethesda Declaration.

The mission of the National Institutes of Health (NIH) is to “seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability.”

In public comments, NIH Director, Dr. Jayanta Bhattacharya, has recognized the critical nature of this mission and has described the NIH as the “crown jewel of American biomedical science”.

Unfortunately, many of the actions of the current administration are inconsistent with this mission and statement. These actions undermine the unique and productive partnership between the federal government and universities, academic medical centers, and research institutes that has served the American people well over many decades. They are damaging the hard-earned trust between the NIH, academia, and the public that is essential for long-term progress.

We commend the NIH staff who have come forward with the “Bethesda Declaration” to share concerns in the spirit of academic freedom, for the good of all. We stand with these committed professionals in support of reversing the harmful actions of this administration. We urge NIH and Department of Health and Human Services (HHS) leadership to work with NIH staff to return the NIH to its mission and to abandon the strategy of using NIH as a tool for achieving political goals unrelated to that mission.

As has been done historically, decisions and monitoring of applications and grants should be conducted by scientifically trained NIH staff through well-established processes including rigorous peer review. Such decisions must not be made by anonymous individuals outside of NIH.

Like any large organization, NIH would benefit periodic review and strategic reforms. However, any reforms should be developed in partnership with NIH staff and other stakeholders through careful and thoughtful analysis. They should not occur through arbitrary changes with no clear purpose or benefits, and without careful consideration of potential risks and adverse consequences—especially to the research participants who have entrusted NIH and its partners with their health.

The current endeavor to Make America Healthy Again (MAHA) refers to some undefined time in the past. Since 1960, the death rate due to heart disease has been cut in half, going from 560 deaths per 100,000 people to approximately 230 deaths per 100,000 today. From 1960 to the present day, the five-year survival rate for childhood leukemia has increased nearly 10-fold, to over 90% for some forms. In 1960, the rate of measles infection was approximately 250 cases per 100,000 people compared with a near zero rate now (at least until recently). These are but a few of many examples. Certainly, much work remains to better treat disease and improve the health of Americans, such as addressing increased rates of obesity, diabetes, and opioid dependency. But, glamorizing a mythical past, while ignoring important progress made through biomedical research, does not enhance the health of American people.

Before the mid-1960s, many of the advances that were ushering in a new era in biology were coming from Europe. However, with support from the NIH, the contributions of American scientists grew over the next decades and America became the internationally recognized hub for biomedical research and training. This, combined with the American entrepreneurial spirit, led to the creation of the biotechnology industry. America was an important partner in the successful international project to sequence the human genome in its entirety and to characterize many variations that contribute to health and disease susceptibility. These advances, and associated technologies, have provided profound insights into the mechanisms of many diseases, both common and rare, that are yielding opportunities for real progress to advance human health, some of which have been realized.

Now is the time to push forward the NIH mission and all that has been built to support it, not to disable it. We urge NIH and HHS leadership to work in partnership with the NIH staff members who have spoken out to refocus on this goal using time-tested processes to award and sustain support for the range of activities that drives the NIH mission, now and into the future.

Nobel Laureate Signatories

Roger Kornberg, PhD, Nobel laureate 2006 for elucidating the mechanism of DNA transcription

Carolyn Bertozzi, PhD, Nobel laureate 2022 for developing chemical tools for studying living organisms

Martin Chalfie, PhD, Nobel laureate 2008 for the development of green fluorescent protein

Joachim Frank, PhD, Nobel laureate 2017 for the development of single particle cryo-electron microscopy

Moungi Bawendi, PhD, Nobel laureate 2023 for the development of quantum dots

Victor Ambros, PhD, Nobel laureate 2024 for the discovery of microRNA

Drew Weissman, MD, PhD, Nobel laureate 2023 for discoveries concerning nucleoside base modifications that enabled the development of effective vaccines 

Ardem Patapoutian, PhD, Nobel laureate 2021 for the discovery of receptors for touch

Aziz Sancar, PhD, Nobel laureate 2015 for elucidation of DNA repair mechanisms

Gregg Semenza, MD, PhD, Nobel laureate 2019 for discoveries of how cells sense and adapt to oxygen availability

Jack Szostak, PhD, Nobel laureate 2009 for discoveries about the function of telomeres and the telomerase enzyme

Carol Greider, PhD, Nobel laureate 2009 for discoveries about the function of telomeres and the telomerase enzyme

Andrew Fire, PhD, Nobel laureate 2006 for the discovery of RNA interference

Robert Horvitz, PhD, Nobel laureate 2002 for the discovery of programmed cell death

David Baker, PhD, Nobel laureate 2024 for protein structure prediction and design

W.E. Moerner, PhD, Nobel laureate 2014 for the development of super-resolution fluorescence microscopy

Rod MacKinnon, MD, Nobel laureate 2003 for discoveries concerning channels in cell membranes

Randy Schekman, PhD, Nobel laureate 2013 for discoveries regarding a major transport system in cells

William Kaelin, MD, PhD, Nobel laureate 2019 for discoveries of how cells sense and adapt to oxygen availability

Brian Kobika, MD, Nobel laureate 2012 for Studies of G-Protein coupled receptors

Thomas C. Südhof, PhD, Nobel laureate 2013 for discoveries regarding a major transport system in cells

May-Britt Moser, PhD in Neuroscience, Prof., Nobel laureate 2014 for work concerning the grid cells in the entorhinal cortex, KISN at NTNU Trondheim

Edvard Moser, Professor, Nobel laureate 2014 for work concerning the grid cells in the entorhinal cortex

Richard Roberts, PhD, Sir, Nobel laureate 1993 for the discovery of introns in eukaryotic DNA and the mechanism of gene-splicing

Jennifer Doudna, PhD, American biochemist, Nobel laureate 2020 for the development of a method for genome editing, CRISPR

Steven Chu, PhD, Prof., 1997 Nobel laureate for research regarding the cooling and trapping of atoms with laser light, Stanford University

Oliver Hart, PhD, Sir, Nobel laureate 2016 for contributions to contract theory, Harvard University

Robert Lefkowitz, MD, Nobel laureate 2012 in Chemistry for studies of G protein coupled receptors

David Politzer, PhD, Nobel laureate 2004 for discovery of asymptotic freedom in quantum chromodynamics

J Michael Bishop, MD, University Prof., Nobel laureate 1989 for discovery the first human oncogene, University of California San Francisco

Elias J. Corey, Prof., Nobel laureate 1990 for his development of the theory and methodology of organic synthesis, Harvard University

David Macmillan, PHD, Nobel laureate 2021 for the development of asymmetric organocatalysis, Princeton University

Adam Riess, Dr., Nobel laureate 2011 for providing evidence that the expansion of the universe is accelerating, Johns Hopkins University

George Smoot, Prof., Nobel laureate 2006 for discovery of the black body form and anisotropy of the cosmic microwave background radiation, Donestia International Physics Center

Paul L Modrich PhD, Nobel laureate 2015 for analysis of DNA repair mechanisms

Francoise Barre Sinoussi, PhD, Nobel laureate 2008 for discovery of HIV, Institut Pasteur

Brian Josephson, Prof. FRS, Nobel laureate 1973 for discovery of the Josephson effect, University of Cambridge

Jean-Marie Lehn, Dr., Prof., Nobel laureate 1987 for synthesis of cryptands, University of Strasboug Institute for Advanced Study (USIAS)

Michel Mayor, PhD, Prof., Nobel laureate 2019 for discovery of the first exoplanet, University of Geneva

Hartmut Michel, Dr, Prof., Nobel laureate 1988 for determination of the first crystal structure of an integral membrane protein, Max Planck Institute of Biophysics

Roger Penrose, Sir, OM, FRS, Nobel laureate 2020 for the discovery that black hole formation is a robust prediction of the general theory of relativity, University of Oxford

Brian Schmidt, Prof., Nobel laureate 2011 for providing evidence that the expansion of the universe is accelerating, Australian National University

Richard Schrock, PhD, Nobel laureate 2005 for work in the area of olefin metathesis, an organic synthesis technique, Massachusetts Institute of Technology

Robert Wilson, Dr., Nobel laureate 1978 for discovery of cosmic microwave background radiation

Johann Deisenhofer, Prof., Nobel laureate 1988 for determination of the first crystal structure of an integral membrane protein

Peter Agre, MD, Nobel laureate 2003 for discoveries concerning channels in cell membranes, Johns Hopkins Bloomberg School of Public Health

Harvey Alter, Dr., Distinguished NIH Scholar, Emeritus, Nobel laureate 2020 for the discovery of the hepatitis C virus, NIH

Cark Wieman, PhD, Prof Emeritus, Nobel laureate 2001 for producing the first true Bose–Einstein condensate, Stanford University

Susumu Tonegawa, PhD, Prof., Nobel laureate 1987 for his discovery of the genetic principle for generation of antibody diversity, MIT

Frank Wilczek, PhD, Nobel laureate 2004 for the discovery of asymptotic freedom in the theory of the strong interaction

Edmund Phelps, Nobel laureate 2006 for analysis of intertemporal trade-offs in macroeconomic policy

Paul Nurse, PhD, Sir, Nobel laureate 2001 for discoveries of protein molecules that control the division of cells in the cell cycle

Ferenc Krausz, PhD, Nobel laureate 2023 for generating and measuring the first attosecond light pulse and used it for capturing electrons’ motion inside atoms

Craig Mello, PhD, Nobel laureate 2006 for the discovery of RNA interference

John Polanyi, Nobel laureate 1986 for research in chemical kinetics.

Shelly Glashow, PhD, Nobel laureate 1979 for contributions to the theory of the unified weak and electromagnetic interaction between elementary particles

Hiroshi Amano, Nobel laureate 2014 for the invention of efficient blue light-emitting diodes which has enabled bright and energy-saving white light sources

Rai Weiss, PhD, Nobel laureate 2017 for decisive contributions to the LIGO detector and the observation of gravitational waves

Michael Rosbash, PhD, Nobel laureate 2017 for discovery of molecular mechanisms controlling the circadian rhythm, Brandeis University

Charles Rice, PhD, Dr., Prof., Nobel laureate 2020 for the discovery of Hepatitis C virus

Lou Ignarro, Nobel laureate 1998 for demonstrating the signaling properties of nitric oxide

Richard Henderson, Nobel laureate 2017 for the development of single particle cryo-electron microscopy

Anne L’Huillier, PhD, Nobel laureate 2022 for pioneering contributions to ultrafast laser science and attosecond physics

John Mather, PhD, Dr., Nobel laureate 2006 for discovery of the blackbody form and anisotropy of the cosmic microwave background radiation

Jerome I Friedman, Prof., Nobel laureate 1990 for pioneering investigations concerning deep inelastic scattering of electrons on protons and bound neutrons, which have been of essential importance for the development of the quark model in particle physics.

Kip Thorne, PhD, Nobel laureate 2017 for contributions to the LIGO detector and the observation of gravitational waves

Notable Signatories

Jeremy M. Berg, PhD, Former Director, National Institute of General Medical Sciences, NIH 

Senator Angela D. Alsobrooks, Democratic Senator from Maryland

Freeman Hrabowski III, PhD, President Emeritus, University of Maryland, Baltimore County

Joshua Gordon, MD, PhD, Former Director, National Institute of Mental Health

Colette Delawalla, MA, MS, Stand Up for Science

Joanne Turner, PhD, Scientist

Carole LaBonne, PhD, President, Society for Developmental Biology

Gregg Gonsalves, PhD, Professor of Public Health and Law

Eric Dishman, Former Director, All of Us Research Program, NIH

Marie Abraham, Vice President, Institute for Patient- and Family-Centered Care

Mustafa Khokha, MD, Pediatrician

Katherine Feemster, MPH, Science & Medical Writer

Emma Mairson, MPH, Public health data scientist

Marian Jarlenski, PhD, MPH, Public health researcher

Scott W. Delaney, ScD JD, Research scientist, Harvard T.H. Chan School of Public Health

Noam Ross, Executive Director, rOpenSci

Annie Cohen, PhD, Alzheimer’s researcher and parent of neurodivergent children

Alondra Nelson, PhD, former Acting Direction, White House Office of Science and Technology Policy

Elias Theodosis, Principal Data Science at Capital One Financial Corporation

Emily York, R.N

Rebecca Groble, Myalgic encephalomyelitis advocate

Anthony Barente, Data scientist

All signatories